A major scientific advance in protein modeling developed by Microsoft Research AI for Science, has been published in Science.

Microsoft's CEO, Satya Nadella, has announced BioEmu-1, a new AI system designed to accelerate drug discovery by decoding ...

Satya Nadella has unveiled BioEmu, Microsoft's new AI initiative aimed at accelerating drug discovery processes.

Centella AI streamlines drug discovery using AI-powered platforms, reducing R&D time and cost with real-world scientific validation ...

Gen Computing Quantum computing, poised to revolutionize industries from cryptography to drug discovery, leverages quantum ...

Understanding protein motion is essential to understanding biology and advancing drug discovery,” said Nadella, in a post on ...

Microsoft's BioEmu, an AI-driven model, decodes protein motion to enhance drug discovery, offering rapid insights into ...

As part of the strategic realignment of its US business, the company has filed for voluntary liquidation under Chapter 7 of ...

Microsoft’s new AI system BioEmu will help decode protein motion and help in faster discovery of drugs, said CEO Satya ...

Wockhardt will exit its loss-making US generic business to focus on antibiotics and diabetes care. The company filed for ...

UTEC is one of Japan’s largest science and technology-focused VCs, with a portfolio spanning more than 150 companies.

A Financial District-based drug discovery company inked a $1 billion licensing agreement with pharmaceutical giant AbbVie to develop its signature cancer drug. IGI Therapeutics SA, a subsidiary of the ...